Cargando…

Response to “Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations”

Detalles Bibliográficos
Autores principales:	Suzuki, Masayuki, Fujimoto, Shigeru, Tanaka, Ryota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2021
Materias:	Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265926/ https://www.ncbi.nlm.nih.gov/pubmed/34039831 http://dx.doi.org/10.5551/jat.62890-R

Ejemplares similares

Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations
por: Kojima, Keisuke, et al.
Publicado: (2021)

Complex Aortic Arch Atherosclerosis in Acute Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation
por: Suzuki, Masayuki, et al.
Publicado: (2021)

Aortogenic embolic stroke after sleeve pneumonectomy with median sternotomy for lung cancer: a case report
por: Suzuki, Hirotoshi, et al.
Publicado: (2021)

Significant Contribution of Aortogenic Mechanism in Ischemic Stroke: Observation of Aortic Plaque Rupture by Angioscopy
por: Higuchi, Yoshiharu, et al.
Publicado: (2022)

Aortogenic Embolic Stroke Diagnosed by a Pathological Examination of Endovascularly Removed Thrombus: An Autopsy Report
por: Usui, Genki, et al.
Publicado: (2019)

Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
por: Alberts, Mark, et al.
Publicado: (2023)

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2016)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

Role of hyperhomocysteine, thyroid dysfunction and their interaction in ischemic stroke patients with non-valvular atrial fibrillation
por: Wang, Lili, et al.
Publicado: (2020)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
por: Le Goff, Laurine, et al.
Publicado: (2023)

Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
por: Kim, Chi Kyung, et al.
Publicado: (2013)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation
por: Yao, Yan, et al.
Publicado: (2017)

Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range
por: Wańkowicz, Paweł, et al.
Publicado: (2018)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Interatrial Block and Risk of Ischemic Stroke – Reply –
por: Wu, Jin-Tao, et al.
Publicado: (2017)

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014)

Characteristics of Pulmonary Vein Enlargement in Non-Valvular Atrial Fibrillation Patients with Stroke
por: Lee, Jung Myung, et al.
Publicado: (2014)

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation: Sub-analysis of the EXPAND Study
por: Uchiyama, Shinichiro, et al.
Publicado: (2018)

Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA(2)DS(2)‐VASc score of 0
por: Choi, Hyohun, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S(4)-BOW-AF)
por: Harris, Daniel E, et al.
Publicado: (2023)

Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation
por: Liu, Ying, et al.
Publicado: (2020)

Infarct Volumes of Patients with Acute Ischemic Stroke Receiving Direct Oral Anticoagulants due to Non-Valvular Atrial Fibrillation
por: Yavasoglu, Nese G., et al.
Publicado: (2021)

Atrial Fibrillation and Cause‐Specific Risks of Pulmonary Embolism and Ischemic Stroke
por: Hald, Erin M., et al.
Publicado: (2018)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Catheter Ablation for Atrial Fibrillation Targeting Incremental Left Ventricular Ejection Fraction　― Reply ―
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation: A Pilot Randomized Trial
por: Kim, Jong S., et al.
Publicado: (2023)

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA(2)DS(2)-VASc score in hemodialysis patients with non-valvular atrial fibrillation
por: Bel-Ange, Anat, et al.
Publicado: (2021)

Left Atrial Structural Remodelling in Non-Valvular Atrial Fibrillation: What Have We Learnt from CMR?
por: Floria, Mariana, et al.
Publicado: (2020)

Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation
por: Rashid, Hashrul N., et al.
Publicado: (2020)

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014)

Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China
por: Hong, Yan, et al.
Publicado: (2017)

Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
por: Hersi, Ahmad S., et al.
Publicado: (2019)

Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
por: Wang, Li, et al.
Publicado: (2013)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units
por: Fastner, Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hb1jb0a54hkmue93c32cmgsnhv